ACT Nabilone is a synthetic cannabinoid that has been approved by the FDA for the treatment of nausea and vomiting associated with chemotherapy in patients who have not responded adequately to conventional antiemetic treatments. This medication works by interacting with the body’s endocannabinoid system, which plays a key role in regulating nausea and vomiting.
Nabilone has been shown to be effective in reducing chemotherapy-induced nausea and vomiting, allowing patients to better tolerate their cancer treatments and maintain their quality of life. It is available in capsule form and is typically taken as needed, as directed by a healthcare provider.
As with any medication, there are potential side effects to be aware of when taking Nabilone. These may include dizziness, drowsiness, dry mouth, and changes in mood or mental status. It is important to discuss any concerns or side effects with your healthcare provider to determine the best course of action.
It is also important to note that Nabilone is a controlled substance and should be used only as prescribed by a healthcare provider. It is not recommended for use in patients with a history of substance abuse or dependence.
Overall, ACT Nabilone can be a valuable tool in managing chemotherapy-induced nausea and vomiting for patients who have not found relief with other treatments. If you or a loved one is experiencing these symptoms, speak with your healthcare provider to see if Nabilone may be a suitable option for you.
EN 
ES 
FR 
PT 
ZH